WebCytek's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 955.5M. Over the last four quarters, Cytek's revenue has grown by 176.8%. … WebApr 12, 2024 · On Tuesday, March 7th, Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock. The shares were sold at an average price of $10.13, for a total value of $202,600.00.
Cytek Company Profile: Stock Performance & Earnings PitchBook
WebFeb 23, 2024 · Cytek Biosciences expects full year 2024 revenue to be in the range of $160 million to $168 million. Webcast Information. Cytek will host a conference call to discuss the fourth quarter 2024 financial results on Wednesday, February 23, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. A webcast of the conference call can be accessed at ... WebCytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results. Form 10-K. Q3. Cytek Biosciences Third Quarter 2024 Earnings Conference Call. Cytek Biosciences Reports Third Quarter 2024 Financial Results. Form 10-Q. Q2. Cytek … nike puffer full-zip rainbow jacket
Cytek Biosciences Reports Fourth Quarter and Full Year 2024
WebFeb 28, 2024 · Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Full year 2024 revenue increased 28%, or 34% on constant currency basis, compared to prior year Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024 WebNov 9, 2024 · Cytek Biosciences First Quarter 2024 Earnings Conference Call. Click here for webcast. Mar 9, 2024 at 8:10 AM PST Cytek Biosciences at the 42nd Annual Cowen Health Care Conference. Click here for webcast. Feb 23, 2024 at 5:00 PM EST WebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry … nike puffer trench coat